By Vince Sullivan ( September 10, 2018, 10:07 PM EDT) -- In a letter to a Delaware vice chancellor made public Monday, Akorn Inc. said that a recent inspection of the drugmaker's New Jersey facility by federal regulators identified areas of concern that had already been raised in its suit against the company that walked away from a $4.3 billion acquisition over alleged data security breaches, and that if anything the report indicates that Akorn is addressing those issues....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.